Compare Air Products & Chemicals, Inc. (APD) vs Incyte Corporation (INCY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Air Products & Chemicals, Inc. vs Incyte Corporation — how do they compare? Air Products & Chemicals, Inc. trades at $308.56 (market cap $68.88B), while Incyte Corporation trades at $120.45 (market cap $24.54B). The key difference: Air Products & Chemicals, Inc. is far larger — about 2.8× Incyte Corporation's market cap, and Air Products & Chemicals, Inc. pays a 2.34% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.
| APD | INCY | |
|---|---|---|
Market Cap | $68.88B | $24.54B |
Sector | Basic Materials | Health |
52-Week High | $314.19 | $129.93 |
52-Week Low | $230.42 | $81.61 |
Enterprise Value | $86.06B | $20.04B |
Dividend Yield | 2.34% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Air Products & Chemicals, Inc.
Since its founding in 1940, Air Products has become one of the leading industrial gas suppliers globally, with operations in 50 countries and 19,000 employees. The company is the largest supplier of hydrogen and helium in the world. It has a unique portfolio serving customers in a number of industries, including chemicals, energy, healthcare, metals, and electronics. Air Products generated $10.3 billion in revenue in fiscal 2021.
Read more on APD →About Incyte Corporation
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →
